Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Citius Oncology, Inc. (CTOR) vs Talphera, Inc. (TLPH)

Citius Oncology, Inc. and Talphera, Inc. are both Drug Manufacturers Specialty & Generic companies. Citius Oncology, Inc. is the larger, with a market value of $97.6M against $60.7M — 1.6× the size. Across the 10 metrics below, Talphera, Inc. leads on 6 and Citius Oncology, Inc. on 4.

Valuation

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m 209.21 2.25
P/B 2.81 6.19 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m 183.86 2.56
Earnings yield (44.76%) (22.88%) (2.99%)
Free cash flow yield (28.37%) (10.82%) 0.00%

Profitability

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Gross margin — 100.00% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (126.58%) (143.36%) (0.40%)
Return on assets (45.20%) (69.60%) (3.32%)
Return on invested capital (67.15%) 0.00% 0.00%

Growth

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (73.07%) 10.01%
EPS growth (last fiscal year) (9.68%) 32.00% —
Revenue growth, 5-year CAGR — (58.55%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 0.00 0.05
Current ratio 0.73 4.29 2.31
Net debt to EBITDA (0.40) 1.50 0.85

Dividend

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — 0.00 0.00

Size

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Market cap 97.63m 60.73m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack